Literature DB >> 4168367

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera.

R D Guttmann, C B Carpenter, R R Lindquist, J P Merrill.   

Abstract

Heterologous rabbit anti-rat thymocyte sera, its immunoglobulin G fraction, and the bivalent and univalent antibody fragments obtained by pepsin digestion are potent immunosuppressive reagents when tested in a system of renal allotransplantation between the LBN F(1) hybrid and Lewis rat strains. The AT F(ab')(2) is not lymphocytotoxic in vitro but has agglutinating ability, while the AT Fab' neither agglutinates nor is cytotoxic to rat lymphocytes, but will inhibit the in vitro reaction. The AT IgG and the F(ab')(2) are more immunogenic in their host than normal rabbit IgG and F(ab')(2), probably due to increased delivery of the antibody to the immune system. Donor pretreatment studies demonstrate that a cross-reacting, highly immunogenic antibody with anti-lymphocyte specificity may bind to renal sites and be transferred to the new host after transplantation. In addition, the crude unabsorbed anti-thymocyte antisera may induce a nephritis characteristic of immune complex disease which can be eliminated by complete absorption with serum proteins. Further in vivo and in vitro evidence is presented that the AT IgG contains small amounts of antibody to glomerular basement membrane antigens and may induce an autologous phase-nephrotoxic nephritis. The amount of in vivo binding by AT IgG to GBM was reduced by subcutaneous rather than intravenous administration. Most of the rabbit antisera tested contain antibody in low titer to sheep erythrocytes and in vivo experiments indicate that the nature of the immunodepressive effect of AT globulin to sheep erythrocytes is due in part to the passive transfer of antibody and is not necessarily due to a specific anti-lymphocyte effect.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168367      PMCID: PMC2138424          DOI: 10.1084/jem.126.6.1099

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  50 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  A simple chromatographic method for preparation of gamma globulin.

Authors:  H B LEVY; H A SOBER
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

4.  Antigen elimination from the blood as an early manifestation of the immune response.

Authors:  D W TALMAGE; F J DIXON; S C BUKANTZ; G J DAMMIN
Journal:  J Immunol       Date:  1951-10       Impact factor: 5.422

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions.

Authors:  Y Iwasaki; K A Porter; J R Amend; T L Marchioro; V Zühlke; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1967-01

7.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02

8.  Enhancement of antibody formation by whole body x-radiation.

Authors:  F J DIXON; P J McCONAHEY
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

9.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

10.  Enhancement of antibody synthesis by 6-mercaptopurine.

Authors:  D Chanmougan; R S Schwartz
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  17 in total

1.  EFFECT OF DONOR PRETREATMENT WITH CYCLOPHOSPHAMIDE ON THE MECHANICAL PERFORMANCE OF THE ISOLATED HEART.

Authors:  S Pitzele; S Sze
Journal:  Cardiovasc Dis       Date:  1976

2.  Prolongation of renal allotransplant in the rat by antigen-antibody mixture.

Authors:  A Byng; G D Pegrum; G B Williams; R A Risdon
Journal:  Ann R Coll Surg Engl       Date:  1973-12       Impact factor: 1.891

3.  The effects of ALG on the murine immune response to sheep erythrocytes.

Authors:  H R Anderson; D W Dresser; G M Iverson; E M Lance; H H Wortis; J Zebra
Journal:  Immunology       Date:  1972-02       Impact factor: 7.397

4.  Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation.

Authors:  E Simpson; S L Nehlsen
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

5.  Human renal allografts. Interpretation of morphologic and immunohistochemical observations.

Authors:  R R Lindquist; R D Guttmann; J P Merrill; G J Dammin
Journal:  Am J Pathol       Date:  1968-11       Impact factor: 4.307

6.  Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum.

Authors:  J F Bach; I Gigli; M Dardenne; J Dormont
Journal:  Immunology       Date:  1972-04       Impact factor: 7.397

7.  Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats.

Authors:  A Z Barabas; K James; R Lannigan
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

8.  Further studies on the effect of anti-lymphocytic antibody on humoral antibody formation.

Authors:  K James; D M Pullar; V S James
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

9.  The intravenous administration of equine antilymphocytic globulin in renal transplant recipients and the detection of circulating antibodies to equine globulin.

Authors:  K James; D M Pullar; J B Morton; R G Dalton; B Nolan; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

10.  Suppression of primary immune response by heterologous anti-lymphocyte sera.

Authors:  C Reuben; K Sundaram; G P Phondke
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.